Decreased serum dependence in the growth of NIH3T3 cells from the overexpression of human nuclear receptor-binding SET-domain-containing protein 1 (NSD1) or fission yeast su(var)3-9, enhancer-of-zeste, trithorax 2 (SET2)
Nuclear receptor‐binding SET‐domain‐containing protein 1 (NSD1), a culprit gene for Sotos syndrome, contains a su(var)3‐9, enhancer‐of‐zeste, trithorax (SET) domain that is responsible for histone methyltransferase activity and other domains such as plant homeodomain (PHD) and proline‐tryptophan‐try...
Saved in:
Published in | Cell biochemistry and function Vol. 26; no. 2; pp. 146 - 150 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.03.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Nuclear receptor‐binding SET‐domain‐containing protein 1 (NSD1), a culprit gene for Sotos syndrome, contains a su(var)3‐9, enhancer‐of‐zeste, trithorax (SET) domain that is responsible for histone methyltransferase activity and other domains such as plant homeodomain (PHD) and proline‐tryptophan‐tryptophan‐proline (PWWP) involved in protein–protein interactions in the C‐terminal half of NSD1. To elucidate the function of NSD1 on cell growth, we overexpressed NSD1 in NIH3T3 cells. Cells overexpressing NSD1 grew in the presence of 2% serum, whereas vector transfected cells did not. Overexpression of the C‐terminal half of NSD1 but not the N‐terminal half of NSD1 also produced cell growth under low serum concentration. Furthermore, overexpression in NIH3T3 of Schizosaccharomyces pombe SET2 which has a SET domain but not PHD or PWWP domains conferred the reduced serum dependence. Thus, the SET domain of NSD1 is involved in cell growth by modulating serum dependence. Copyright © 2007 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | istex:18571FF2256833CD5062EC3C0FB73A83C5ACA548 ArticleID:CBF1413 The Ministry of Education, Culture, Sports, Science and Technology of Japan ark:/67375/WNG-ND41QGT2-1 |
ISSN: | 0263-6484 1099-0844 |
DOI: | 10.1002/cbf.1413 |